Work

Abstract 2166: Rapamycin can overcome ABT-737 resistance in patient-derived SCLC xenograft models.

Year: 2013

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2013-2166

Authors: Nick Connis, Eric E. Gardner, John T. Poirier, Chandrashekhar D. Kamat, Leslie Cope, Charles M. Rudin, Christine L. Hann

Institution: Johns Hopkins University

Language: English

Topic: Cell death mechanisms and regulation

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2033348084

Cites:

Cited by:

Related to: 10